DiaMedica Therapeutics Inc. (DMAC) NASDAQ

$3.38 -0.02 (-0.59%)

Market Cap: $89.36M

As of 01/14/22 04:00 PM EST. Market closed.

(DMAC)

DiaMedica Therapeutics Inc. (DMAC) NASDAQ

$3.38 -0.02 (-0.59%)

Market Cap: $89.36M

As of 01/14/22 04:00 PM EST. Market closed.

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney ... read more

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Address
.
KEY STATS
Open
$3.41
Previous Close
$3.40
Days Range
$3.27 - $3.45
52 week range
$3 - $10.88
Volume
72,894
Avg. Volume (30 days)
125,345
Market Cap
$89.36M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
26,439,217
Open
$3.41
Previous Close
$3.40
Days Range
$3.27 - $3.45
52 week range
$3 - $10.88
Volume
72,894
Avg. Volume (30 days)
125,345
Market Cap
$89.36M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
26,439,217

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR DIAMEDICA THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Burroughs Amy L. Director Jan 03, 2022 Option Exercise $3.58 11,182 40,032 56,132 Jan 03, 2022, 04:39 PM
Pilnik Richard D. Director Jan 03, 2022 Option Exercise $3.58 23,762 85,068 119,327 Jan 03, 2022, 04:26 PM
Parsons James T. Director Jan 03, 2022 Option Exercise $3.58 16,773 60,047 38,509 Jan 03, 2022, 04:21 PM
Giuffre Randall Michael Director Jan 03, 2022 Option Exercise $3.58 15,026 53,793 110,225 Jan 03, 2022, 04:09 PM
ALCORN HARRY W JR SVP, Clinical Operations Sep 15, 2021 Buy $3.80 15,000 56,960 43,582 Sep 15, 2021, 04:37 PM
Burroughs Amy L. Director Aug 16, 2021 Buy $3.15 44,950 141,593 44,950 Aug 17, 2021, 04:11 PM
Pilnik Richard D. Director Aug 16, 2021 Buy $3.27 15,000 49,064 95,565 Aug 17, 2021, 04:05 PM
ALCORN HARRY W JR Senior VP, Clinical Operations Aug 16, 2021 Buy $3.07 399 1,225 399 Aug 16, 2021, 04:27 PM
ALCORN HARRY W JR Senior VP, Clinical Operations Aug 16, 2021 Buy $3.09 20,322 62,829 28,582 Aug 16, 2021, 04:27 PM
Pauls Dietrich John President and CEO Aug 16, 2021 Buy $3.14 5,000 15,700 35,804 Aug 16, 2021, 04:19 PM
Kellen Scott CFO and Secretary Aug 16, 2021 Buy $3.15 10,000 31,463 22,290 Aug 16, 2021, 04:10 PM
Giuffre Randall Michael Director Jan 01, 2021 Option Exercise $8.23 7,441 61,239 116,029 Jan 04, 2021, 04:33 PM
Parsons James T. Director Jan 01, 2021 Option Exercise $8.23 7,745 63,741 21,947 Jan 04, 2021, 04:21 PM
Pilnik Richard D. Director Jan 01, 2021 Option Exercise $8.23 9,719 79,987 80,565 Jan 04, 2021, 04:12 PM
Pilnik Richard D. Director Dec 04, 2020 Buy $5.37 10,000 53,697 70,846 Dec 04, 2020, 05:46 PM
Giuffre Randall Michael Director Nov 20, 2020 Buy $4.26 15,000 63,912 108,588 Nov 23, 2020, 04:22 PM
Kellen Scott CFO and Secretary Nov 09, 2020 Buy $4.19 2,000 8,387 12,290 Nov 10, 2020, 08:16 AM
Giuffre Randall Michael Director Jun 01, 2020 Option Exercise $4.59 7,784 35,729 93,588 Jun 02, 2020, 04:59 PM
Parsons James T. Director Jun 01, 2020 Option Exercise $4.59 8,102 37,188 14,202 Jun 02, 2020, 04:49 PM
Pilnik Richard D. Director Jun 01, 2020 Option Exercise $4.59 10,168 46,671 60,846 Jun 02, 2020, 04:33 PM
Kellen Scott CFO and Secretary Aug 19, 2019 Buy $2.43 3,000 7,290 10,290 Aug 19, 2019, 04:24 PM
Pilnik Richard D. Director Aug 16, 2019 Buy $2.56 7,840 20,039 50,678 Aug 19, 2019, 06:45 AM
ALCORN HARRY W JR Chief Medical Officer Aug 16, 2019 Buy $2.67 7,260 19,365 8,260 Aug 16, 2019, 04:35 PM
Pauls Dietrich John President and CEO Aug 16, 2019 Buy $2.68 1,000 2,677 30,804 Aug 16, 2019, 04:31 PM
Pilnik Richard D. Director May 31, 2019 Buy $2.80 19,000 53,200 42,838 May 31, 2019, 04:11 PM
Kellen Scott CFO and Secretary May 24, 2019 Buy $2.94 4,000 11,770 7,290 May 28, 2019, 07:17 AM
ALCORN HARRY W JR Chief Medical Officer Mar 27, 2019 Buy $4.46 150 668 1,150 Mar 29, 2019, 04:15 PM
Xiao Zhenyu Director Dec 11, 2018 Buy $4.00 3,250 13,000 7,100 Dec 11, 2018, 04:48 PM
Verdoorn Todd A. Chief Scientific Officer Dec 11, 2018 Buy $4.00 1,000 4,000 2,000 Dec 11, 2018, 04:42 PM
Pilnik Richard D. Director Dec 11, 2018 Buy $4.00 6,250 25,000 23,838 Dec 11, 2018, 04:37 PM
Pauls Dietrich John President and CEO Dec 11, 2018 Buy $4.00 5,000 20,000 29,804 Dec 11, 2018, 04:31 PM
Parsons James T. Director Dec 11, 2018 Buy $4.00 2,250 9,000 6,100 Dec 11, 2018, 04:27 PM
Kellen Scott CFO and Secretary Dec 11, 2018 Buy $4.00 1,250 5,000 3,290 Dec 11, 2018, 04:22 PM
Giuffre Randall Michael Director Dec 11, 2018 Buy $4.00 11,250 45,000 85,804 Dec 11, 2018, 04:17 PM
ALCORN HARRY W JR Chief Medical Officer Dec 11, 2018 Buy $4.00 1,000 4,000 1,000 Dec 11, 2018, 04:08 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Burroughs Amy L. Director 01/03/2022 40,032
Pilnik Richard D. Director 01/03/2022 85,068
Parsons James T. Director 01/03/2022 60,047
Giuffre Randall Michael Director 01/03/2022 53,793
ALCORN HARRY W JR SVP, Clinical Operations 09/15/2021 56,960
Burroughs Amy L. Director 08/16/2021 141,593
Pilnik Richard D. Director 08/16/2021 49,064
ALCORN HARRY W JR Senior VP, Clinical Operations 08/16/2021 1,225
ALCORN HARRY W JR Senior VP, Clinical Operations 08/16/2021 62,829
Pauls Dietrich John President and CEO 08/16/2021 15,700
Kellen Scott CFO and Secretary 08/16/2021 31,463
Giuffre Randall Michael Director 01/01/2021 61,239
Parsons James T. Director 01/01/2021 63,741
Pilnik Richard D. Director 01/01/2021 79,987
Pilnik Richard D. Director 12/04/2020 53,697
Giuffre Randall Michael Director 11/20/2020 63,912
Kellen Scott CFO and Secretary 11/09/2020 8,387
Giuffre Randall Michael Director 06/01/2020 35,729
Parsons James T. Director 06/01/2020 37,188
Pilnik Richard D. Director 06/01/2020 46,671
Kellen Scott CFO and Secretary 08/19/2019 7,290
Pilnik Richard D. Director 08/16/2019 20,039
ALCORN HARRY W JR Chief Medical Officer 08/16/2019 19,365
Pauls Dietrich John President and CEO 08/16/2019 2,677
Pilnik Richard D. Director 05/31/2019 53,200
Kellen Scott CFO and Secretary 05/24/2019 11,770
ALCORN HARRY W JR Chief Medical Officer 03/27/2019 668
Xiao Zhenyu Director 12/11/2018 13,000
Verdoorn Todd A. Chief Scientific Officer 12/11/2018 4,000
Pilnik Richard D. Director 12/11/2018 25,000
Pauls Dietrich John President and CEO 12/11/2018 20,000
Parsons James T. Director 12/11/2018 9,000
Kellen Scott CFO and Secretary 12/11/2018 5,000
Giuffre Randall Michael Director 12/11/2018 45,000
ALCORN HARRY W JR Chief Medical Officer 12/11/2018 4,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
0.47%
1Q
09/30/2021
03/31/2021
0.52%
2Q
09/30/2021
09/30/2020
28.74%
4Q
09/30/2021
06/30/2020
38.47%
5Q
09/30/2021
03/31/2020
43.91%
6Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.47%
1Q
03/31/2021
0.52%
2Q
09/30/2020
28.74%
4Q
06/30/2020
38.47%
5Q
03/31/2020
43.91%
6Q
Load More